Fig. 2: Kaplan–Meier estimates of survival. | Nature Communications

Fig. 2: Kaplan–Meier estimates of survival.

From: Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma: a single-arm phase II trial

Fig. 2: Kaplan–Meier estimates of survival.The alternative text for this image may have been generated using AI.

a Overall survival in the per-protocol set (n = 46). b Progression-free survival in the per-protocol set (n = 46). c Overall survival in the intention-to-treat population (n = 49). d Progression-free survival in the intention-to-treat population (n = 49). Kaplan–Meier survival curves are shown with 95% confidence intervals (shaded areas). Source data are provided as a Source Data file.

Back to article page